Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.

Slides:



Advertisements
Similar presentations
GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells  Mohamad.
Advertisements

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial  Eman A. Elgindy, Ahmed.
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Norbert Gleicher, Andrea Weghofer, David H. Barad 
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response  William L. Ledger, Bart C.J.M. Fauser, Paul.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?  Adrija Kumar Datta, Ariel Zosmer, Amanda Tozer, Luca Sabatini, Colin.
Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles  Ze Wu, Rong Li, Yanping Ma, Bo Deng,
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A
Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders  Li-Jun Ding, Bin Wang, Xiao-Yue Shen, Gui-Jun Yan, Ning-Yuan.
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis  Annelies Overbeek, Frank J. Broekmans, Wouter.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
Patient-tailored ovarian stimulation for in vitro fertilization
A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation  Hermann M. Behre, Colin.
Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist.
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)  Yanping Kuang, Qiuju Chen,
Amir Wiser, Einat Shalom-Paz, Jordana H
HDlive ultrasound images in assisted reproduction treatment
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Utility of age-specific serum anti-Müllerian hormone concentrations
Electroacupuncture decreases the progression of ovarian hyperstimulation syndrome in a rat model  Li Chen, Hai-Xiang Sun, You-Bing Xia, Liu-Cai Sui, Ji.
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Ongoing pregnancies from early retrieval of prematurely developing antral follicles after DHEA supplementation  Murat Sönmezer, Aylin Pelin Çil, Kutluk.
Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve  Bulent Urman, Ebru Alper, Kayhan Yakin, Ozgur.
Reproductive BioMedicine Online
Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.
Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF  Kirsty.
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial  Vivian Chi Yan Lee, Carina Chi Wai Chan,
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study  R Matorras, B Prieto, A Exposito, R.
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF–ICSI  Jianjun Zhou, Shanshan Wang, Bin Wang, Junxia.
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling  Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
Is parental consanguinity associated with reduced ovarian reserve?
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
Claudio Manna, Loris Nanni, Alessandra Lumini, Sebastiana Pappalardo 
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight  Suying.
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated.
Presentation transcript:

Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong Shao, Wenwen Bian, Haiyan Fu, Juanjuan Xu, Liucai Sui, Bing Yao, Meiling Li  Reproductive BioMedicine Online  Volume 36, Issue 1, Pages 20-25 (January 2018) DOI: 10.1016/j.rbmo.2017.09.003 Copyright © 2017 Terms and Conditions

Figure 1 Receiver operating characteristic curve analysis showing the area under the curve of advanced glycation end products (AGE) in follicular fluid, day 3 serum anti-Müllerian hormone (AMH) and antral follicle count (AFC) for the prediction of below target response to ovarian stimulation. Reproductive BioMedicine Online 2018 36, 20-25DOI: (10.1016/j.rbmo.2017.09.003) Copyright © 2017 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.